Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cambrex Zenara Facility Gains EU GMP Approval | Contract Pharma

What are you searching for?

Sign in
Breaking News

Cambrex Zenara Facility Gains EU GMP Approval

Cambrex Corp. has received GMP compliance certification from the Danish Medicines Agency (DKMA) for its manufacturing site in Hyderabad, India, following an audit conducted in October 2010.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cambrex Corp. has received GMP compliance certification from the Danish Medicines Agency (DKMA) for its manufacturing site in Hyderabad, India, following an audit conducted in October 2010. The DKMA Certificate is accepted by all EU Health Authorities and by authorities of several other countries.

The DKMA certification allows the company to expedite the launch of Nicotine Replacement Therapy (NRT) products in Europe, in addition to offering finished dosage forms of other pharmaceutical products to European customers through an integrated value chain.

Ashok Narasimhan, president of Cambrex Zenara, said, “We are very pleased with the results of the DKMA inspection. This commercially important and significant milestone for Cambrex confirms our commitment to quality in every aspect of operations management and reflects our efforts to sustain and continuously improve quality platforms.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters